Delivery Order SPE2DR25D3003-SPE2DR26F5RA9
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,678.08 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units) with an ultimate completion date of January 13, 2026. This non-set-aside, firm fixed-price delivery order was competitively awarded and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order valued at $5,892.92 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 8 mg tablets (30-count units) on January 14, 2026, with a completion date of January 15, 2026. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,736.48 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 8 mg tablets (30-count packages) with a completion date of December 10, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a delivery order valued at $8,935.16 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 MG tablets (30 count) on January 27, 2026. This firm fixed-price delivery order, which is expected to be completed by January 28, 2026, represents a competitive award with no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. As a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $16,136.43 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 8 mg tablets (30-count packages) with an ultimate completion date of January 12, 2026. This competitively awarded, firm fixed-price delivery order was issued with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major...
- The Defense Logistics Agency awarded a $7,527.37 delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 8 mg tablets (30-count units) with an ultimate completion date of July 23, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen is a major pharmaceutical distributor and critical federal healthcare vendor that...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Ondansetron ODT 8 mg tablets (30-count) valued at $1,636.14 under a firm fixed-price contract. The award was made on November 5, 2025, with an ultimate completion date of November 6, 2025, with no set-aside designation. Performance will be executed from the contractor's location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery...
- The Defense Logistics Agency awarded a delivery order valued at $17.5K to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 8 mg tablets (30-count packaging) on January 20, 2026, with an ultimate completion date of January 21, 2026. This competitively awarded, non-set-aside contract employs firm fixed-price pricing and will be performed at the awardee's corporate headquarters in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $2,727.46 to AmerisourceBergen Drug Corp on January 14, 2026, for the supply of Ondansetron ODT 8 mg tablets in quantities of 30. The contract, which is competitively awarded with no set-aside designation, utilizes firm fixed-price pricing and is scheduled for completion by January 15, 2026. The place of performance is the contractor's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $39,241.13 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 8 mg tablets (30-count packages) with an ultimate completion date of November 13, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- SPE2DR25D3003Indefinite Delivery Contract
- SPE2DR25D3003-SPE2DR26F5RA9Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,759.80 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 8 mg tablets (30-count packages) on February 3, 2026, with an ultimate completion date of February 4, 2026. This firm fixed-price delivery order represents a non-set-aside competitive award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including medications, vaccines, and specialized medical commodities. The DLA's Medical Supply Chain relies on such prime vendor relationships to ensure consistent availability of essential pharmaceutical products across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 2/2/26 |